ilShinBioBase Co

ilShinBioBase Co Rule of 40

The Rule of 40 of ilShinBioBase Co (068330.KQ) as of Oct 21, 2026 is 65.72 %. In the previous year, Rule of 40 was -13.27 % — a change of -595.10% (higher).

Rule of 40

65.72 %

YoY

-595.10%

Last updated:

Rule of 40 of ilShinBioBase Co is 2025 65.72 % . Rule of 40 of ilShinBioBase Co was 2024 -13.27 % . It decreases by -595.10% higher compared to the previous year.

The ilShinBioBase Co Rule of 40 history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Rule of 40
Date
Rule of 40
Jan 1, 2018
39.58 KRW
Jan 1, 2019
54.20 KRW
Jan 1, 2020
31.01 KRW
Jan 1, 2021
47.80 KRW
Jan 1, 2022
9.08 KRW
Jan 1, 2023
18.25 KRW
Jan 1, 2024
-13.27 KRW
Jan 1, 2025
65.72 KRW
The ilShinBioBase Co Rule of 40 history
YEARRule of 40YoY
65.72 %-595.10%
-13.27 %-172.74%
18.25 %+101.07%
9.08 %-81.01%
47.80 %+54.15%
31.01 %-42.80%
54.20 %+36.96%
39.58 %+175.89%
14.34 %-45.05%
26.10 %+9.96%
23.74 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

ilShinBioBase Co Stock analysis

What does ilShinBioBase Co do? ilShinbiobase Co., Ltd. generates revenue by manufacturing and distributing industrial refrigeration equipment. Its product portfolio includes freeze dryers for drying sera, antibiotics, enzymes, laboratory samples, and foods; programmable freeze dryers for early-stage research with temperature, time, and vacuum control; deep freezers for biotechnology applications; and ice makers for research laboratories. The company also offers blood bank refrigerators, pharmaceutical refrigerators, shakers, and food processing equipment. These products are sold domestically and to overseas markets, targeting biotechnology firms, pharmaceutical companies, research institutions, and laboratories requiring specialized refrigeration solutions. The company's revenue streams primarily come from the sale of its industrial refrigeration equipment to customers in the biotechnology, pharmaceutical, and research sectors. Products like programmable freeze dryers and deep freezers are specifically designed for early-stage research and biotechnology applications, catering to the needs of laboratories and biotech firms. Blood bank refrigerators and pharmaceutical refrigerators serve healthcare and pharmaceutical industries, while ice makers and food processing equipment support research and food-related applications. ilShinbiobase’s business model focuses on providing specialized refrigeration equipment for niche markets. The company targets biotechnology and pharmaceutical industries with deep freezers and blood bank refrigerators, while programmable freeze dryers and shakers are marketed to research laboratories. Overseas and domestic distribution channels ensure market reach, with products tailored to specific industry requirements such as serum drying in pharmaceuticals and sample preservation in laboratories. ilShinBioBase Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about ilShinBioBase Co stock

Rule of 40 of ilShinBioBase Co is 65.72 % in 2025.

On Eulerpool you can find the complete historical development of Rule of 40 ilShinBioBase Co since 2006 – with annual values, charts, and detailed analysis.

The Rule of 40 states that a company's revenue growth rate plus profit margin should exceed 40%. It is widely used to evaluate SaaS and high-growth companies.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Quality — ilShinBioBase Co

All Key Metrics — ilShinBioBase Co